

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.63205440 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.63205440 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.34091278 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.34091278 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.87239792 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.20922452 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.20922452 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.20922452 |
| 9 | glyoxylate metabolic process (GO:0046487) | 6.07627166 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.00934906 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.94253653 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.84738643 |
| 13 | cysteine metabolic process (GO:0006534) | 5.72740979 |
| 14 | * tryptophan metabolic process (GO:0006568) | 5.61068978 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.47860670 |
| 16 | urea metabolic process (GO:0019627) | 5.45182664 |
| 17 | urea cycle (GO:0000050) | 5.45182664 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.43447397 |
| 19 | serine family amino acid catabolic process (GO:0009071) | 5.35140161 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.21888237 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.17832184 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.07525726 |
| 23 | protein carboxylation (GO:0018214) | 5.06007069 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.06007069 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.03746120 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.03011676 |
| 27 | homocysteine metabolic process (GO:0050667) | 5.01678337 |
| 28 | bile acid metabolic process (GO:0008206) | 4.96655138 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.94855857 |
| 30 | regulation of protein activation cascade (GO:2000257) | 4.92945392 |
| 31 | * aromatic amino acid family metabolic process (GO:0009072) | 4.88168803 |
| 32 | amino-acid betaine metabolic process (GO:0006577) | 4.84811797 |
| 33 | * lysine catabolic process (GO:0006554) | 4.77028827 |
| 34 | * lysine metabolic process (GO:0006553) | 4.77028827 |
| 35 | * alpha-amino acid catabolic process (GO:1901606) | 4.75829239 |
| 36 | tyrosine metabolic process (GO:0006570) | 4.72315531 |
| 37 | cellular ketone body metabolic process (GO:0046950) | 4.62375476 |
| 38 | glycine metabolic process (GO:0006544) | 4.61525260 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.60503580 |
| 40 | regulation of complement activation (GO:0030449) | 4.59672606 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.55343220 |
| 42 | serine family amino acid metabolic process (GO:0009069) | 4.50926937 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.49763892 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.46677449 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.46677449 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.46677449 |
| 47 | * cellular amino acid catabolic process (GO:0009063) | 4.42527069 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.41364281 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.41364281 |
| 50 | negative regulation of sterol transport (GO:0032372) | 4.38405077 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.38405077 |
| 52 | coenzyme catabolic process (GO:0009109) | 4.35354929 |
| 53 | glutamate metabolic process (GO:0006536) | 4.33318419 |
| 54 | serine family amino acid biosynthetic process (GO:0009070) | 4.33315129 |
| 55 | amine catabolic process (GO:0009310) | 4.32349153 |
| 56 | cellular biogenic amine catabolic process (GO:0042402) | 4.32349153 |
| 57 | cellular modified amino acid catabolic process (GO:0042219) | 4.26658238 |
| 58 | cellular glucuronidation (GO:0052695) | 4.24690504 |
| 59 | imidazole-containing compound metabolic process (GO:0052803) | 4.23297455 |
| 60 | phospholipid efflux (GO:0033700) | 4.21682868 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.21488604 |
| 62 | drug catabolic process (GO:0042737) | 4.21169380 |
| 63 | ethanol oxidation (GO:0006069) | 4.18525196 |
| 64 | benzene-containing compound metabolic process (GO:0042537) | 4.16303274 |
| 65 | * indolalkylamine metabolic process (GO:0006586) | 4.13236261 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 4.08855234 |
| 67 | short-chain fatty acid metabolic process (GO:0046459) | 4.04457688 |
| 68 | aldehyde catabolic process (GO:0046185) | 4.03898926 |
| 69 | ketone body metabolic process (GO:1902224) | 4.00008148 |
| 70 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.95462052 |
| 71 | drug transmembrane transport (GO:0006855) | 3.93873413 |
| 72 | acetyl-CoA metabolic process (GO:0006084) | 3.92293886 |
| 73 | urate metabolic process (GO:0046415) | 3.92248516 |
| 74 | * organic acid catabolic process (GO:0016054) | 3.91962450 |
| 75 | * carboxylic acid catabolic process (GO:0046395) | 3.91962450 |
| 76 | arginine metabolic process (GO:0006525) | 3.91010941 |
| 77 | cholesterol efflux (GO:0033344) | 3.87725525 |
| 78 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.83598315 |
| 79 | uronic acid metabolic process (GO:0006063) | 3.80088683 |
| 80 | glucuronate metabolic process (GO:0019585) | 3.80088683 |
| 81 | low-density lipoprotein particle remodeling (GO:0034374) | 3.78721439 |
| 82 | 2-oxoglutarate metabolic process (GO:0006103) | 3.77251111 |
| 83 | exogenous drug catabolic process (GO:0042738) | 3.74913035 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 3.72831906 |
| 85 | cofactor catabolic process (GO:0051187) | 3.72540117 |
| 86 | L-serine metabolic process (GO:0006563) | 3.72287879 |
| 87 | fibrinolysis (GO:0042730) | 3.70486599 |
| 88 | fatty acid beta-oxidation (GO:0006635) | 3.67249564 |
| 89 | oxidative phosphorylation (GO:0006119) | 3.66131331 |
| 90 | monocarboxylic acid catabolic process (GO:0072329) | 3.65587670 |
| 91 | regulation of bile acid biosynthetic process (GO:0070857) | 3.62349337 |
| 92 | carnitine metabolic process (GO:0009437) | 3.60923324 |
| 93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.60460277 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.60460277 |
| 95 | blood coagulation, intrinsic pathway (GO:0007597) | 3.60459506 |
| 96 | cholesterol homeostasis (GO:0042632) | 3.59984068 |
| 97 | branched-chain amino acid catabolic process (GO:0009083) | 3.59038122 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.57155660 |
| 99 | regulation of mitochondrial translation (GO:0070129) | 3.56806267 |
| 100 | regulation of cholesterol homeostasis (GO:2000188) | 3.56503815 |
| 101 | * fatty acid oxidation (GO:0019395) | 3.56178902 |
| 102 | drug metabolic process (GO:0017144) | 3.55266507 |
| 103 | sterol homeostasis (GO:0055092) | 3.55058126 |
| 104 | flavonoid metabolic process (GO:0009812) | 3.54664126 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.53790809 |
| 106 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.48639097 |
| 107 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.44517952 |
| 108 | branched-chain amino acid metabolic process (GO:0009081) | 3.37936482 |
| 109 | maturation of 5.8S rRNA (GO:0000460) | 3.34647752 |
| 110 | nucleobase biosynthetic process (GO:0046112) | 3.31727077 |
| 111 | DNA strand elongation (GO:0022616) | 3.31131895 |
| 112 | rRNA modification (GO:0000154) | 3.28952585 |
| 113 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.22446553 |
| 114 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.19732020 |
| 115 | oxaloacetate metabolic process (GO:0006107) | 3.16609049 |
| 116 | establishment of integrated proviral latency (GO:0075713) | 3.15875954 |
| 117 | DNA deamination (GO:0045006) | 3.12323873 |
| 118 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.10631081 |
| 119 | ATP synthesis coupled proton transport (GO:0015986) | 3.10631081 |
| 120 | purine nucleobase biosynthetic process (GO:0009113) | 3.09444817 |
| 121 | pseudouridine synthesis (GO:0001522) | 3.06854558 |
| 122 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.04567833 |
| 123 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.01677349 |
| 124 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.99977350 |
| 125 | ubiquinone biosynthetic process (GO:0006744) | 2.97736752 |
| 126 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.96718635 |
| 127 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.96718635 |
| 128 | S-adenosylmethionine metabolic process (GO:0046500) | 2.88974312 |
| 129 | amino acid salvage (GO:0043102) | 2.87815525 |
| 130 | L-methionine salvage (GO:0071267) | 2.87815525 |
| 131 | L-methionine biosynthetic process (GO:0071265) | 2.87815525 |
| 132 | negative regulation of ligase activity (GO:0051352) | 2.85496228 |
| 133 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.85496228 |
| 134 | deoxyribonucleotide catabolic process (GO:0009264) | 2.85120251 |
| 135 | * aspartate family amino acid catabolic process (GO:0009068) | 2.84328614 |
| 136 | epoxygenase P450 pathway (GO:0019373) | 2.84271938 |
| 137 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.83969766 |
| 138 | quinone biosynthetic process (GO:1901663) | 2.83836956 |
| 139 | ribosomal small subunit assembly (GO:0000028) | 2.83813721 |
| 140 | deoxyribose phosphate catabolic process (GO:0046386) | 2.79749472 |
| 141 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.79632554 |
| 142 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.79526804 |
| 143 | negative regulation of B cell apoptotic process (GO:0002903) | 2.78273605 |
| 144 | establishment of viral latency (GO:0019043) | 2.74477492 |
| 145 | omega-hydroxylase P450 pathway (GO:0097267) | 2.74371396 |
| 146 | proteasome assembly (GO:0043248) | 2.73808868 |
| 147 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.73668617 |
| 148 | spliceosomal snRNP assembly (GO:0000387) | 2.71842068 |
| 149 | NADH metabolic process (GO:0006734) | 2.70084960 |
| 150 | formation of translation preinitiation complex (GO:0001731) | 2.70038749 |
| 151 | mitochondrial RNA metabolic process (GO:0000959) | 2.69753966 |
| 152 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.68269202 |
| 153 | regulation of translational fidelity (GO:0006450) | 2.65887600 |
| 154 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.65456946 |
| 155 | tricarboxylic acid cycle (GO:0006099) | 2.64788330 |
| 156 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.64539132 |
| 157 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.62647811 |
| 158 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.62647811 |
| 159 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.62647811 |
| 160 | ribosome assembly (GO:0042255) | 2.61879694 |
| 161 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.61659566 |
| 162 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.61659566 |
| 163 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.61555142 |
| 164 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.61479575 |
| 165 | CENP-A containing nucleosome assembly (GO:0034080) | 2.61110955 |
| 166 | ribosome biogenesis (GO:0042254) | 2.60862525 |
| 167 | DNA strand renaturation (GO:0000733) | 2.59878658 |
| 168 | viral mRNA export from host cell nucleus (GO:0046784) | 2.59807781 |
| 169 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.59206650 |
| 170 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.59206650 |
| 171 | ubiquinone metabolic process (GO:0006743) | 2.58777496 |
| 172 | DNA unwinding involved in DNA replication (GO:0006268) | 2.58550782 |
| 173 | biotin metabolic process (GO:0006768) | 2.58490855 |
| 174 | protein targeting to mitochondrion (GO:0006626) | 2.58288564 |
| 175 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.58095790 |
| 176 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.57749757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.36900370 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21138998 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.86892039 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.40610537 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.34661196 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.24265148 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.21667861 |
| 8 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.11641862 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.17138301 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.90822894 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.65013113 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.39505166 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.34073143 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.26878918 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.15257372 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.02521404 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.85227368 |
| 18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.84693066 |
| 19 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.82988323 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.75138266 |
| 21 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.70591397 |
| 22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.57824889 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.48897862 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.38322654 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28380285 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.27861843 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.23571670 |
| 28 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.18137911 |
| 29 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.17496581 |
| 30 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.15663014 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10707379 |
| 32 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.09983907 |
| 33 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.04528063 |
| 34 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9436423 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.99099133 |
| 36 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.99082822 |
| 37 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.96862233 |
| 38 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.96724936 |
| 39 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.96407289 |
| 40 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.95774398 |
| 41 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.79463233 |
| 42 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.79406366 |
| 43 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.79155574 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.75934202 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.74456272 |
| 46 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.70662108 |
| 47 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.69257766 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68494307 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67675119 |
| 50 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.65956593 |
| 51 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.63278899 |
| 52 | MYC_22102868_ChIP-Seq_BL_Human | 1.58473732 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57571539 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55455978 |
| 55 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.50599099 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.49302204 |
| 57 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.48753294 |
| 58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.46930435 |
| 59 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.46360370 |
| 60 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43697201 |
| 61 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43177497 |
| 62 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.41582268 |
| 63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39422103 |
| 64 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.39189988 |
| 65 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.38459767 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37056660 |
| 67 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35744295 |
| 68 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35034625 |
| 69 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.31693713 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31526604 |
| 71 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31507993 |
| 72 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28897096 |
| 73 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.28362332 |
| 74 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.27014116 |
| 75 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22566400 |
| 76 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.18377624 |
| 77 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.16543178 |
| 78 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15000049 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13866890 |
| 80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12944415 |
| 81 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08883877 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08881878 |
| 83 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08313141 |
| 84 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.06933677 |
| 85 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06032077 |
| 86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05977358 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05597274 |
| 88 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.05079342 |
| 89 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03505012 |
| 90 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.03251260 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02866056 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02033352 |
| 93 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00950595 |
| 94 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.00483153 |
| 95 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99938083 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98049607 |
| 97 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97920217 |
| 98 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95188661 |
| 99 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.94791848 |
| 100 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94092405 |
| 101 | P68_20966046_ChIP-Seq_HELA_Human | 0.92314822 |
| 102 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.90499319 |
| 103 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.88860969 |
| 104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88110928 |
| 105 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.87910881 |
| 106 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.87757235 |
| 107 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87703107 |
| 108 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.87426264 |
| 109 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87289796 |
| 110 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86824539 |
| 111 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.86778742 |
| 112 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.86503740 |
| 113 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86370596 |
| 114 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86006760 |
| 115 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85502352 |
| 116 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85126833 |
| 117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84676052 |
| 118 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81823255 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.81529690 |
| 120 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80963580 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78530926 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78099665 |
| 123 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77941087 |
| 124 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.76952018 |
| 125 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.75240737 |
| 126 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69868299 |
| 127 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69093466 |
| 128 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.67038109 |
| 129 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66179470 |
| 130 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65960838 |
| 131 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65392094 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63911597 |
| 133 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63554575 |
| 134 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.61543716 |
| 135 | AR_20517297_ChIP-Seq_VCAP_Human | 0.59843376 |
| 136 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59341670 |
| 137 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.58633904 |
| 138 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.56853262 |
| 139 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.55795695 |
| 140 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.55163812 |
| 141 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.54636471 |
| 142 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.54544429 |
| 143 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.53425995 |
| 144 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53197237 |
| 145 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52534042 |
| 146 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52402792 |
| 147 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50931791 |
| 148 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.50557461 |
| 149 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50531817 |
| 150 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.49794598 |
| 151 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.49794598 |
| 152 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47642849 |
| 153 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46452480 |
| 154 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45818899 |
| 155 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.45731264 |
| 156 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45553589 |
| 157 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45498599 |
| 158 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44813655 |
| 159 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.44122268 |
| 160 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.43251984 |
| 161 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.41873398 |
| 162 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41867714 |
| 163 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.41788075 |
| 164 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41068736 |
| 165 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.40895290 |
| 166 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.40059681 |
| 167 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39879109 |
| 168 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39855521 |
| 169 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.38977717 |
| 170 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.37915675 |
| 171 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37632928 |
| 172 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.37632918 |
| 173 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.37395304 |
| 174 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.37313258 |
| 175 | GATA2_19941826_ChIP-Seq_K562_Human | 0.36603115 |
| 176 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.36135225 |
| 177 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.35818444 |
| 178 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.35546042 |
| 179 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.35139465 |
| 180 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34979911 |
| 181 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.34799692 |
| 182 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.34455029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.23230781 |
| 2 | MP0005360_urolithiasis | 7.61625948 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.27402279 |
| 4 | MP0005365_abnormal_bile_salt | 6.08806978 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.14085245 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.35604423 |
| 7 | MP0010094_abnormal_chromosome_stability | 3.93783587 |
| 8 | MP0003252_abnormal_bile_duct | 3.81779717 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.43081194 |
| 10 | MP0003693_abnormal_embryo_hatching | 3.42259902 |
| 11 | MP0008058_abnormal_DNA_repair | 3.34433389 |
| 12 | MP0003111_abnormal_nucleus_morphology | 3.28147936 |
| 13 | MP0005332_abnormal_amino_acid | 3.07151881 |
| 14 | MP0009840_abnormal_foam_cell | 3.04894583 |
| 15 | MP0003195_calcinosis | 3.04022077 |
| 16 | MP0005083_abnormal_biliary_tract | 3.00870150 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.65490222 |
| 18 | MP0003077_abnormal_cell_cycle | 2.45600897 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.38899725 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.23325778 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.13715431 |
| 22 | MP0000609_abnormal_liver_physiology | 2.11947394 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 2.08148246 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.02582566 |
| 25 | MP0004957_abnormal_blastocyst_morpholog | 2.01104432 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.88986924 |
| 27 | MP0008007_abnormal_cellular_replicative | 1.88882394 |
| 28 | MP0003868_abnormal_feces_composition | 1.85129677 |
| 29 | MP0001764_abnormal_homeostasis | 1.77003281 |
| 30 | MP0003786_premature_aging | 1.76494429 |
| 31 | MP0008932_abnormal_embryonic_tissue | 1.71596822 |
| 32 | MP0005075_abnormal_melanosome_morpholog | 1.67078389 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64051251 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.58169497 |
| 35 | MP0005451_abnormal_body_composition | 1.57074069 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.54269618 |
| 37 | MP0003186_abnormal_redox_activity | 1.49448328 |
| 38 | * MP0009643_abnormal_urine_homeostasis | 1.48579485 |
| 39 | MP0009697_abnormal_copulation | 1.44171846 |
| 40 | MP0002019_abnormal_tumor_incidence | 1.40835140 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.34983442 |
| 42 | MP0008057_abnormal_DNA_replication | 1.29341957 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.28520716 |
| 44 | MP0003567_abnormal_fetal_cardiomyocyte | 1.27469286 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.25518139 |
| 46 | MP0003011_delayed_dark_adaptation | 1.23578512 |
| 47 | MP0001730_embryonic_growth_arrest | 1.22440600 |
| 48 | MP0000313_abnormal_cell_death | 1.19665488 |
| 49 | MP0002398_abnormal_bone_marrow | 1.18454420 |
| 50 | MP0000598_abnormal_liver_morphology | 1.18237045 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.18061552 |
| 52 | MP0002722_abnormal_immune_system | 1.13850252 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.09906889 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.09559286 |
| 55 | MP0001800_abnormal_humoral_immune | 1.09135385 |
| 56 | MP0000358_abnormal_cell_content/ | 1.07018166 |
| 57 | MP0005647_abnormal_sex_gland | 1.05575729 |
| 58 | MP0002429_abnormal_blood_cell | 1.05224734 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.04042927 |
| 60 | MP0009278_abnormal_bone_marrow | 1.02262887 |
| 61 | MP0009764_decreased_sensitivity_to | 1.00596732 |
| 62 | MP0002132_abnormal_respiratory_system | 0.98243201 |
| 63 | MP0006292_abnormal_olfactory_placode | 0.97762771 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 0.97629486 |
| 65 | MP0000716_abnormal_immune_system | 0.96355310 |
| 66 | MP0009763_increased_sensitivity_to | 0.96210505 |
| 67 | MP0005000_abnormal_immune_tolerance | 0.94534558 |
| 68 | MP0000604_amyloidosis | 0.93719798 |
| 69 | MP0000350_abnormal_cell_proliferation | 0.92970214 |
| 70 | MP0005670_abnormal_white_adipose | 0.91489290 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 0.91460102 |
| 72 | MP0001545_abnormal_hematopoietic_system | 0.91460102 |
| 73 | MP0001529_abnormal_vocalization | 0.90268266 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 0.89696432 |
| 75 | MP0009642_abnormal_blood_homeostasis | 0.89207275 |
| 76 | MP0008469_abnormal_protein_level | 0.88269547 |
| 77 | MP0002420_abnormal_adaptive_immunity | 0.87684725 |
| 78 | MP0001819_abnormal_immune_cell | 0.87634985 |
| 79 | MP0005380_embryogenesis_phenotype | 0.87328958 |
| 80 | MP0001672_abnormal_embryogenesis/_devel | 0.87328958 |
| 81 | MP0005220_abnormal_exocrine_pancreas | 0.85657471 |
| 82 | MP0002876_abnormal_thyroid_physiology | 0.85556516 |
| 83 | MP0002080_prenatal_lethality | 0.85093039 |
| 84 | MP0002006_tumorigenesis | 0.84746928 |
| 85 | MP0005408_hypopigmentation | 0.84619538 |
| 86 | MP0001756_abnormal_urination | 0.83203458 |
| 87 | MP0002078_abnormal_glucose_homeostasis | 0.82404799 |
| 88 | MP0010307_abnormal_tumor_latency | 0.81779016 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.81561939 |
| 90 | MP0002254_reproductive_system_inflammat | 0.81068010 |
| 91 | MP0002452_abnormal_antigen_presenting | 0.80687257 |
| 92 | MP0002653_abnormal_ependyma_morphology | 0.80543388 |
| 93 | MP0002723_abnormal_immune_serum | 0.79124868 |
| 94 | MP0004043_abnormal_pH_regulation | 0.77357117 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.76124233 |
| 96 | MP0000747_muscle_weakness | 0.75743477 |
| 97 | MP0008877_abnormal_DNA_methylation | 0.75419578 |
| 98 | MP0001661_extended_life_span | 0.75210692 |
| 99 | MP0002166_altered_tumor_susceptibility | 0.75162661 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 0.74762077 |
| 101 | MP0005646_abnormal_pituitary_gland | 0.74630323 |
| 102 | MP0000490_abnormal_crypts_of | 0.73984156 |
| 103 | MP0005535_abnormal_body_temperature | 0.73356625 |
| 104 | MP0002971_abnormal_brown_adipose | 0.72784055 |
| 105 | MP0004130_abnormal_muscle_cell | 0.72560467 |
| 106 | MP0000372_irregular_coat_pigmentation | 0.72355931 |
| 107 | MP0001881_abnormal_mammary_gland | 0.72284440 |
| 108 | MP0006035_abnormal_mitochondrial_morpho | 0.72107922 |
| 109 | MP0003984_embryonic_growth_retardation | 0.71698497 |
| 110 | MP0010368_abnormal_lymphatic_system | 0.71690696 |
| 111 | MP0005266_abnormal_metabolism | 0.71604756 |
| 112 | MP0002088_abnormal_embryonic_growth/wei | 0.69993094 |
| 113 | MP0005025_abnormal_response_to | 0.69886224 |
| 114 | MP0001929_abnormal_gametogenesis | 0.69806865 |
| 115 | MP0005334_abnormal_fat_pad | 0.67399218 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.65109319 |
| 117 | MP0003329_amyloid_beta_deposits | 0.56756236 |
| 118 | MP0003690_abnormal_glial_cell | 0.56651302 |
| 119 | MP0002837_dystrophic_cardiac_calcinosis | 0.55787045 |
| 120 | MP0005448_abnormal_energy_balance | 0.51612899 |
| 121 | MP0003718_maternal_effect | 0.51309334 |
| 122 | MP0009053_abnormal_anal_canal | 0.50453782 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.50375784 |
| 124 | MP0000639_abnormal_adrenal_gland | 0.50345995 |
| 125 | MP0005395_other_phenotype | 0.49659205 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.49446140 |
| 127 | MP0002928_abnormal_bile_duct | 0.48488840 |
| 128 | MP0001765_abnormal_ion_homeostasis | 0.45432521 |
| 129 | MP0003953_abnormal_hormone_level | 0.43889566 |
| 130 | MP0002822_catalepsy | 0.43761433 |
| 131 | MP0003724_increased_susceptibility_to | 0.42638915 |
| 132 | MP0008873_increased_physiological_sensi | 0.42531149 |
| 133 | MP0009672_abnormal_birth_weight | 0.41956037 |
| 134 | MP0005464_abnormal_platelet_physiology | 0.41264882 |
| 135 | MP0000230_abnormal_systemic_arterial | 0.41188491 |
| 136 | MP0008872_abnormal_physiological_respon | 0.40214389 |
| 137 | MP0008874_decreased_physiological_sensi | 0.39746088 |
| 138 | MP0004782_abnormal_surfactant_physiolog | 0.39531780 |
| 139 | MP0005058_abnormal_lysosome_morphology | 0.38806454 |
| 140 | MP0002796_impaired_skin_barrier | 0.34914093 |
| 141 | MP0003075_altered_response_to | 0.32662451 |
| 142 | MP0002970_abnormal_white_adipose | 0.31773415 |
| 143 | MP0005166_decreased_susceptibility_to | 0.31660748 |
| 144 | MP0009115_abnormal_fat_cell | 0.31392627 |
| 145 | MP0002168_other_aberrant_phenotype | 0.30877662 |
| 146 | MP0003436_decreased_susceptibility_to | 0.30769314 |
| 147 | MP0001853_heart_inflammation | 0.29108816 |
| 148 | MP0004264_abnormal_extraembryonic_tissu | 0.28941795 |
| 149 | MP0004147_increased_porphyrin_level | 0.28682119 |
| 150 | MP0009384_cardiac_valve_regurgitation | 0.26853805 |
| 151 | MP0001845_abnormal_inflammatory_respons | 0.26808653 |
| 152 | MP0004381_abnormal_hair_follicle | 0.26089600 |
| 153 | MP0000579_abnormal_nail_morphology | 0.26005935 |
| 154 | * MP0002135_abnormal_kidney_morphology | 0.25701325 |
| 155 | MP0002269_muscular_atrophy | 0.25244222 |
| 156 | MP0001944_abnormal_pancreas_morphology | 0.25058880 |
| 157 | MP0000249_abnormal_blood_vessel | 0.24938272 |
| 158 | MP0003959_abnormal_lean_body | 0.24539232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.29339556 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.93841549 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.74312182 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.41577113 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.04916084 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.01517690 |
| 7 | Xanthomatosis (HP:0000991) | 5.99659597 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.22587914 |
| 9 | Hyperammonemia (HP:0001987) | 4.80944286 |
| 10 | Complement deficiency (HP:0004431) | 4.79582934 |
| 11 | Hyperglycinemia (HP:0002154) | 4.71871303 |
| 12 | Hyperglycinuria (HP:0003108) | 4.55453633 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.46824348 |
| 14 | Joint hemorrhage (HP:0005261) | 4.40946492 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.40291101 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.40291101 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.40013546 |
| 18 | * Ketosis (HP:0001946) | 4.34532361 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.32506911 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.30043128 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.19585972 |
| 22 | Epidermoid cyst (HP:0200040) | 4.17269621 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.11059074 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.08944684 |
| 25 | Hypoglycemic coma (HP:0001325) | 4.08781617 |
| 26 | Fat malabsorption (HP:0002630) | 3.98889362 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.87081358 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.84005768 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 3.78176596 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.77376718 |
| 31 | Microvesicular hepatic steatosis (HP:0001414) | 3.71507811 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.62639613 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.50769813 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.50358680 |
| 35 | Ketoacidosis (HP:0001993) | 3.49192280 |
| 36 | Abnormality of complement system (HP:0005339) | 3.44623337 |
| 37 | Hepatocellular necrosis (HP:0001404) | 3.40346966 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.35334641 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.34852271 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.31939950 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.31688910 |
| 42 | Hypercholesterolemia (HP:0003124) | 3.29874438 |
| 43 | Gout (HP:0001997) | 3.28404899 |
| 44 | Ragged-red muscle fibers (HP:0003200) | 3.27140314 |
| 45 | Reduced antithrombin III activity (HP:0001976) | 3.24137959 |
| 46 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.22174310 |
| 47 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.22174310 |
| 48 | Hepatic necrosis (HP:0002605) | 3.21755510 |
| 49 | Agammaglobulinemia (HP:0004432) | 3.20697309 |
| 50 | Increased muscle lipid content (HP:0009058) | 3.17378198 |
| 51 | Increased intramyocellular lipid droplets (HP:0012240) | 3.13272557 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 3.10275523 |
| 53 | Steatorrhea (HP:0002570) | 3.05162181 |
| 54 | Increased serum lactate (HP:0002151) | 3.04887696 |
| 55 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.04555342 |
| 56 | Increased CSF lactate (HP:0002490) | 3.02576084 |
| 57 | Progressive muscle weakness (HP:0003323) | 2.99720054 |
| 58 | Mitochondrial inheritance (HP:0001427) | 2.96781440 |
| 59 | Acute encephalopathy (HP:0006846) | 2.95085854 |
| 60 | Abnormal number of erythroid precursors (HP:0012131) | 2.93000453 |
| 61 | Hepatocellular carcinoma (HP:0001402) | 2.92373317 |
| 62 | Lactic acidosis (HP:0003128) | 2.91796338 |
| 63 | Lethargy (HP:0001254) | 2.91654719 |
| 64 | * Metabolic acidosis (HP:0001942) | 2.90248337 |
| 65 | Type I transferrin isoform profile (HP:0003642) | 2.86718821 |
| 66 | Lipid accumulation in hepatocytes (HP:0006561) | 2.82099516 |
| 67 | Colon cancer (HP:0003003) | 2.80777530 |
| 68 | 3-Methylglutaconic aciduria (HP:0003535) | 2.80410067 |
| 69 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.78899565 |
| 70 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.77649820 |
| 71 | * Dicarboxylic aciduria (HP:0003215) | 2.77649820 |
| 72 | Birth length less than 3rd percentile (HP:0003561) | 2.77632710 |
| 73 | Generalized aminoaciduria (HP:0002909) | 2.75003154 |
| 74 | Spontaneous abortion (HP:0005268) | 2.71931403 |
| 75 | Acute necrotizing encephalopathy (HP:0006965) | 2.71120792 |
| 76 | Vascular calcification (HP:0004934) | 2.70035903 |
| 77 | Testicular atrophy (HP:0000029) | 2.69844699 |
| 78 | Cerebral edema (HP:0002181) | 2.69670234 |
| 79 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.66715205 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 2.61997572 |
| 81 | Increased hepatocellular lipid droplets (HP:0006565) | 2.61237282 |
| 82 | Skin nodule (HP:0200036) | 2.61060324 |
| 83 | Myocardial infarction (HP:0001658) | 2.59789202 |
| 84 | Methylmalonic aciduria (HP:0012120) | 2.52895010 |
| 85 | Hypoglycemic seizures (HP:0002173) | 2.48758145 |
| 86 | Irritability (HP:0000737) | 2.45725465 |
| 87 | IgM deficiency (HP:0002850) | 2.45142843 |
| 88 | Renal Fanconi syndrome (HP:0001994) | 2.42670825 |
| 89 | Pancytopenia (HP:0001876) | 2.42016613 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.41841983 |
| 91 | Cerebral palsy (HP:0100021) | 2.41772382 |
| 92 | Acanthocytosis (HP:0001927) | 2.39859424 |
| 93 | Neonatal onset (HP:0003623) | 2.39842927 |
| 94 | Proximal tubulopathy (HP:0000114) | 2.39795277 |
| 95 | Abnormal gallbladder morphology (HP:0012437) | 2.38158487 |
| 96 | Cardiovascular calcification (HP:0011915) | 2.37345420 |
| 97 | Abnormality of glycolysis (HP:0004366) | 2.37169991 |
| 98 | Malnutrition (HP:0004395) | 2.37011977 |
| 99 | Vomiting (HP:0002013) | 2.36854755 |
| 100 | Increased serum pyruvate (HP:0003542) | 2.36079447 |
| 101 | Exercise intolerance (HP:0003546) | 2.34347837 |
| 102 | Abnormal protein glycosylation (HP:0012346) | 2.34040935 |
| 103 | Abnormal glycosylation (HP:0012345) | 2.34040935 |
| 104 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.34040935 |
| 105 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.34040935 |
| 106 | Abnormality of T cell physiology (HP:0011840) | 2.33993373 |
| 107 | Multiple enchondromatosis (HP:0005701) | 2.33569276 |
| 108 | Methylmalonic acidemia (HP:0002912) | 2.32972194 |
| 109 | Cholelithiasis (HP:0001081) | 2.32628528 |
| 110 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.29519123 |
| 111 | Late onset (HP:0003584) | 2.28013148 |
| 112 | Alkalosis (HP:0001948) | 2.27227306 |
| 113 | Enlarged kidneys (HP:0000105) | 2.25948860 |
| 114 | Hyperuricemia (HP:0002149) | 2.25463136 |
| 115 | Increased purine levels (HP:0004368) | 2.25463136 |
| 116 | Colitis (HP:0002583) | 2.24924872 |
| 117 | Pancreatitis (HP:0001733) | 2.23235865 |
| 118 | Brushfield spots (HP:0001088) | 2.20125195 |
| 119 | Mitral stenosis (HP:0001718) | 2.19192380 |
| 120 | Abnormal gallbladder physiology (HP:0012438) | 2.18271847 |
| 121 | Cholecystitis (HP:0001082) | 2.18271847 |
| 122 | Glycosuria (HP:0003076) | 2.16156573 |
| 123 | Abnormality of urine glucose concentration (HP:0011016) | 2.16156573 |
| 124 | Severe combined immunodeficiency (HP:0004430) | 2.12959401 |
| 125 | Glomerulonephritis (HP:0000099) | 2.12777806 |
| 126 | Sensorimotor neuropathy (HP:0007141) | 2.12490316 |
| 127 | Aplastic anemia (HP:0001915) | 2.10299566 |
| 128 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09053657 |
| 129 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.08948408 |
| 130 | Hydroxyprolinuria (HP:0003080) | 2.07882380 |
| 131 | Abnormality of proline metabolism (HP:0010907) | 2.07882380 |
| 132 | Rickets (HP:0002748) | 2.07421591 |
| 133 | Ependymoma (HP:0002888) | 2.05527727 |
| 134 | Progressive macrocephaly (HP:0004481) | 2.01325260 |
| 135 | Rhabdomyolysis (HP:0003201) | 2.00116800 |
| 136 | B lymphocytopenia (HP:0010976) | 1.99122672 |
| 137 | Renal cortical cysts (HP:0000803) | 1.99091703 |
| 138 | Esophageal varix (HP:0002040) | 1.98531544 |
| 139 | Abnormal cartilage morphology (HP:0002763) | 1.98316533 |
| 140 | Amyloidosis (HP:0011034) | 1.98295454 |
| 141 | Thrombophlebitis (HP:0004418) | 1.98281844 |
| 142 | Respiratory difficulties (HP:0002880) | 1.98146736 |
| 143 | Abnormality of the preputium (HP:0100587) | 1.97159920 |
| 144 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.96724560 |
| 145 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96681668 |
| 146 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.96653212 |
| 147 | Poikilocytosis (HP:0004447) | 1.95434429 |
| 148 | Abnormality of the gallbladder (HP:0005264) | 1.95376283 |
| 149 | Combined immunodeficiency (HP:0005387) | 1.94405061 |
| 150 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93876282 |
| 151 | Menorrhagia (HP:0000132) | 1.92752576 |
| 152 | Emotional lability (HP:0000712) | 1.90686423 |
| 153 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90563173 |
| 154 | Reticulocytopenia (HP:0001896) | 1.89767938 |
| 155 | Abnormality of iron homeostasis (HP:0011031) | 1.88451893 |
| 156 | Nausea (HP:0002018) | 1.87654324 |
| 157 | Gingival bleeding (HP:0000225) | 1.87603968 |
| 158 | Elevated hepatic transaminases (HP:0002910) | 1.87536926 |
| 159 | Mesangial abnormality (HP:0001966) | 1.86751315 |
| 160 | Recurrent viral infections (HP:0004429) | 1.85014862 |
| 161 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.84776215 |
| 162 | Abnormality of alanine metabolism (HP:0010916) | 1.84776215 |
| 163 | Hyperalaninemia (HP:0003348) | 1.84776215 |
| 164 | Neutropenia (HP:0001875) | 1.84366960 |
| 165 | Abnormality of vitamin metabolism (HP:0100508) | 1.83229521 |
| 166 | Abnormality of B cell number (HP:0010975) | 1.82896456 |
| 167 | Hypophosphatemic rickets (HP:0004912) | 1.80469939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 8.32735694 |
| 2 | VRK2 | 5.20047036 |
| 3 | FGFR4 | 4.24466285 |
| 4 | SIK1 | 4.18017705 |
| 5 | ERN1 | 4.11555918 |
| 6 | BUB1 | 3.27404827 |
| 7 | SMG1 | 3.07044112 |
| 8 | INSRR | 2.94718126 |
| 9 | TAOK3 | 2.86527631 |
| 10 | CDC7 | 2.74937254 |
| 11 | ERBB4 | 2.60656333 |
| 12 | PKN2 | 2.50347714 |
| 13 | FLT3 | 2.41269877 |
| 14 | ZAK | 2.33142812 |
| 15 | VRK1 | 2.32276789 |
| 16 | SRPK1 | 2.20643267 |
| 17 | PBK | 2.19439841 |
| 18 | TLK1 | 2.18883874 |
| 19 | MST1R | 2.04681790 |
| 20 | MAP2K4 | 2.03801233 |
| 21 | MAP4K2 | 2.02511714 |
| 22 | BMPR1B | 1.96505542 |
| 23 | MAPK11 | 1.92806342 |
| 24 | CDK8 | 1.86951355 |
| 25 | NUAK1 | 1.84382677 |
| 26 | KIT | 1.79569437 |
| 27 | PIK3CG | 1.79037328 |
| 28 | TRIB3 | 1.62171207 |
| 29 | TYK2 | 1.54650385 |
| 30 | PINK1 | 1.53225024 |
| 31 | TAF1 | 1.52879202 |
| 32 | ABL2 | 1.50158538 |
| 33 | TTK | 1.44451160 |
| 34 | CDK19 | 1.43809141 |
| 35 | TESK2 | 1.42179565 |
| 36 | NEK9 | 1.41836104 |
| 37 | TSSK6 | 1.39915335 |
| 38 | LATS1 | 1.39368206 |
| 39 | ATR | 1.37866939 |
| 40 | MAP4K1 | 1.37296779 |
| 41 | NME1 | 1.37199747 |
| 42 | FRK | 1.29481309 |
| 43 | STK38L | 1.28946976 |
| 44 | KDR | 1.28608333 |
| 45 | PTK6 | 1.26657019 |
| 46 | EIF2AK1 | 1.25924468 |
| 47 | MAP2K3 | 1.24919726 |
| 48 | MAP3K7 | 1.23944365 |
| 49 | WNK3 | 1.22348732 |
| 50 | TNK2 | 1.22143479 |
| 51 | PRKAA2 | 1.18907370 |
| 52 | WNK4 | 1.17720999 |
| 53 | JAK2 | 1.17602011 |
| 54 | DAPK2 | 1.15504866 |
| 55 | PLK3 | 1.10276487 |
| 56 | PLK4 | 1.05899522 |
| 57 | CDK7 | 0.99557331 |
| 58 | RPS6KA5 | 0.98870770 |
| 59 | TGFBR1 | 0.97799158 |
| 60 | STK4 | 0.97021058 |
| 61 | MAP3K3 | 0.96883044 |
| 62 | CHEK2 | 0.96281734 |
| 63 | GRK6 | 0.95818299 |
| 64 | PDK4 | 0.95350220 |
| 65 | PDK3 | 0.95350220 |
| 66 | FGFR2 | 0.94888724 |
| 67 | MST4 | 0.89577175 |
| 68 | AURKA | 0.88857523 |
| 69 | CLK1 | 0.88316770 |
| 70 | MAPK4 | 0.87383307 |
| 71 | TBK1 | 0.87057420 |
| 72 | PLK1 | 0.86562002 |
| 73 | SCYL2 | 0.86315634 |
| 74 | OXSR1 | 0.85035159 |
| 75 | MET | 0.83850006 |
| 76 | MAPK15 | 0.83571420 |
| 77 | PRPF4B | 0.83207204 |
| 78 | PRKCZ | 0.82960419 |
| 79 | IRAK3 | 0.82612016 |
| 80 | AURKB | 0.82510231 |
| 81 | MAP2K6 | 0.79068593 |
| 82 | MAPK12 | 0.79027485 |
| 83 | TIE1 | 0.78826024 |
| 84 | MKNK1 | 0.78081359 |
| 85 | ERBB2 | 0.76398775 |
| 86 | DAPK1 | 0.75733828 |
| 87 | MAP3K14 | 0.75171406 |
| 88 | PRKAA1 | 0.74867650 |
| 89 | JAK1 | 0.74848094 |
| 90 | JAK3 | 0.74113504 |
| 91 | RPS6KB2 | 0.73364605 |
| 92 | CDK9 | 0.71859347 |
| 93 | PRKACG | 0.71284540 |
| 94 | NEK1 | 0.70066769 |
| 95 | GSK3A | 0.69363122 |
| 96 | MAP3K11 | 0.68712631 |
| 97 | EIF2AK2 | 0.68423385 |
| 98 | DYRK2 | 0.66712321 |
| 99 | MAP3K10 | 0.66002321 |
| 100 | STK16 | 0.64311994 |
| 101 | PHKG1 | 0.63433323 |
| 102 | PHKG2 | 0.63433323 |
| 103 | DYRK1B | 0.63274436 |
| 104 | TAOK2 | 0.62073331 |
| 105 | FES | 0.61616936 |
| 106 | CAMK2G | 0.61152840 |
| 107 | CAMK1D | 0.60059110 |
| 108 | SGK3 | 0.59888868 |
| 109 | TGFBR2 | 0.58581225 |
| 110 | PIM1 | 0.57888717 |
| 111 | PIM2 | 0.56799076 |
| 112 | SYK | 0.56346674 |
| 113 | IKBKB | 0.55408559 |
| 114 | CDK6 | 0.55392197 |
| 115 | EPHB1 | 0.54603954 |
| 116 | ATM | 0.54261945 |
| 117 | TXK | 0.53332282 |
| 118 | PASK | 0.52853399 |
| 119 | BTK | 0.51635276 |
| 120 | MAP3K8 | 0.50558683 |
| 121 | MAPKAPK5 | 0.50553451 |
| 122 | CSNK2A2 | 0.50547706 |
| 123 | CSK | 0.49884199 |
| 124 | LRRK2 | 0.49471631 |
| 125 | EIF2AK3 | 0.49375169 |
| 126 | CHEK1 | 0.49369860 |
| 127 | PTK2 | 0.49320897 |
| 128 | SGK2 | 0.48760705 |
| 129 | EEF2K | 0.48160964 |
| 130 | SGK494 | 0.47749487 |
| 131 | SGK223 | 0.47749487 |
| 132 | PDK2 | 0.47443426 |
| 133 | AKT2 | 0.47322808 |
| 134 | CDK4 | 0.47230058 |
| 135 | PDPK1 | 0.46968681 |
| 136 | CSNK2A1 | 0.46429744 |
| 137 | CSF1R | 0.45439029 |
| 138 | MAPK7 | 0.44897204 |
| 139 | ACVR1B | 0.43309703 |
| 140 | CSNK1G1 | 0.42543210 |
| 141 | EPHA3 | 0.40998376 |
| 142 | BRSK1 | 0.39972331 |
| 143 | NEK2 | 0.39965651 |
| 144 | PRKCQ | 0.39298509 |
| 145 | MAP3K5 | 0.37873089 |
| 146 | LYN | 0.36646402 |
| 147 | MAP2K1 | 0.36430981 |
| 148 | GRK1 | 0.36365839 |
| 149 | ITK | 0.35983871 |
| 150 | CDK2 | 0.34751636 |
| 151 | BRSK2 | 0.34599602 |
| 152 | IGF1R | 0.34574892 |
| 153 | AKT3 | 0.34184582 |
| 154 | IKBKE | 0.33706057 |
| 155 | PRKCI | 0.33466721 |
| 156 | MAP3K6 | 0.33258123 |
| 157 | DAPK3 | 0.32688083 |
| 158 | RIPK1 | 0.32453186 |
| 159 | MTOR | 0.30121752 |
| 160 | CDK3 | 0.30019309 |
| 161 | CAMK4 | 0.28991028 |
| 162 | FGFR3 | 0.28930889 |
| 163 | PRKCG | 0.28867320 |
| 164 | PDK1 | 0.26988389 |
| 165 | MAP2K2 | 0.26803188 |
| 166 | RET | 0.26577131 |
| 167 | MYLK | 0.24242362 |
| 168 | PRKCA | 0.23479241 |
| 169 | NME2 | 0.23362962 |
| 170 | IRAK2 | 0.20966253 |
| 171 | IRAK1 | 0.20501890 |
| 172 | EGFR | 0.19675136 |
| 173 | PIK3CA | 0.19043303 |
| 174 | CSNK1G3 | 0.18640802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.25506591 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37008824 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33871678 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25197180 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.95996242 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90167120 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.81885164 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.76938823 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.63816532 |
| 10 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60422555 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.59960081 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.59023737 |
| 13 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.48911124 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.44597200 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.33084289 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.31452392 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.17182496 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.16926834 |
| 19 | Mismatch repair_Homo sapiens_hsa03430 | 2.09307297 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 2.06693228 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05884383 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.92975332 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87064632 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87016743 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85229491 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84247960 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.84100123 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83547311 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82970793 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80727688 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79709363 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.78882647 |
| 33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.78723046 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78560226 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.77473948 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70886520 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.69123289 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68409259 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63329903 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61898990 |
| 41 | RNA polymerase_Homo sapiens_hsa03020 | 1.59909992 |
| 42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.58374040 |
| 43 | Spliceosome_Homo sapiens_hsa03040 | 1.56683009 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53013576 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51159396 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50834816 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48068743 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 1.46616210 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 1.43968276 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43965387 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.39047257 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36777291 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35510527 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33418943 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.32137834 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30021053 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28854242 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28473949 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.28439777 |
| 60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.23586622 |
| 61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.15914645 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.11824963 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 1.11312674 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10697802 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10574625 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07434800 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05125105 |
| 68 | RNA degradation_Homo sapiens_hsa03018 | 1.04565865 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03969853 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02732636 |
| 71 | RNA transport_Homo sapiens_hsa03013 | 1.02127196 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99198420 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94565644 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91710305 |
| 75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.90978842 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86706078 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86414580 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84689759 |
| 79 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.82906187 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78761634 |
| 81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78286107 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77760499 |
| 83 | Purine metabolism_Homo sapiens_hsa00230 | 0.77093878 |
| 84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73406654 |
| 85 | * Lysine degradation_Homo sapiens_hsa00310 | 0.73307933 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70683160 |
| 87 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68505136 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66168016 |
| 89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.64582019 |
| 90 | Cell cycle_Homo sapiens_hsa04110 | 0.63501406 |
| 91 | Asthma_Homo sapiens_hsa05310 | 0.62680498 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56616298 |
| 93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53902360 |
| 94 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.52879720 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.46144022 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45860893 |
| 97 | Allograft rejection_Homo sapiens_hsa05330 | 0.41553681 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36520808 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35886163 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32564841 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32132906 |
| 102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31861805 |
| 103 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.31838392 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25743630 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.23927401 |
| 106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22627444 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.20902915 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20889892 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19511044 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13288301 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07839817 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.06631654 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01654699 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00817926 |
| 115 | Lysosome_Homo sapiens_hsa04142 | -0.2425875 |
| 116 | Other glycan degradation_Homo sapiens_hsa00511 | -0.2243988 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | -0.2057552 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2021082 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2005677 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1980249 |
| 121 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1940047 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1907559 |
| 123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1901218 |
| 124 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1771302 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1729361 |
| 126 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1608794 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1434487 |
| 128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1382853 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1372728 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1137808 |
| 131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0953150 |
| 132 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0913203 |
| 133 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0466596 |

